News

Check out our new member resource hub where you can find all recent Benefactor articles as well as additional resources on topics such as vision benefits, prescription benefits, human resources, and mindfulness!  Enter Hub

Benecard Association teamed up with drug administrator Benecard Services L.L.C. to launch a new three-month meditation program From Free Form Minds at no charge for its members to help address the effects of COVID-19. With prescriptions for...

The past couple of weeks have seen incredible changes for all of us—from business practices to the way we live our lives. As we brace ourselves for several more weeks of social distancing and uncertainty it’s important to take a moment to...

A recent study1 links uncorrected vision loss to an increased risk of death among seniors. While the study couldn’t provide a definitive reason for the connection, the researchers involved do have a theory. Researchers speculate the cause for...

Over the last several years, the misuse of prescription drugs has become an epidemic in the United States. While many are aware of the opioid epidemic, the United States is still facing a major drug crisis in 2024. According to the Substance Abuse and...

To be successful, we need goals, or rather, SMART goals. SMART stands for specific, measurable, attainable, realistic, and timely. If you have a resolution or goal you want to accomplish, it's time to take out a pen and paper and write it...

We are excited to announce that both Benecard Services and National Vision Administrators are offering Continuing Education (CE) courses. Sponsored by Cape School, our CE courses are FREE and are approved in many states across the country. We will come...

Agency Warns Eight Companies Regarding Their Unapproved Ophthalmic Drugs Press release originally posted on www.fda.gov The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved...

Gilead Sciences’ Hepatitis C Virus (HCV) Treatment Drug Sovaldi came as a medical breakthrough with a 90% cure rate.  However, this medical breakthrough comes with an eye popping price tag in the U.S. with no price break in sight.  If...

The rapidly escalating costs of specialty medications present one of healthcare’s most pressing challenges. With specialty drugs now accounting for over 75% of drug development1, plan sponsors and patients alike face mounting financial...